Cycloruthenated Self‐Assembly with Metabolic Inhibition to Efficiently Overcome Multidrug Resistance in Cancers

Author:

Li Jia12,Zeng Leli123,Wang Zheng4,Chen Hengxing1,Fang Shuo1,Wang Jinquan5,Cai Chao‐Yun3,Xing Enming1,Liao Xinxing2,Li Zhi‐Wei2,Ashby Charles R.3,Chen Zhe‐Sheng3ORCID,Chao Hui12,Pan Yihang1

Affiliation:

1. Guangdong Provincial Key Laboratory of Digestive Cancer Research Precision Medicine Center The Seventh Affiliated Hospital Sun Yat‐Sen University Shenzhen Guangdong 518107 P. R. China

2. MOE Key Laboratory of Bioinorganic and Synthetic Chemistry School of Chemistry Sun Yat‐Sen University Guangzhou 510275 P. R. China

3. College of Pharmacy and Health Sciences St. John's University New York NY 11439 USA

4. College of Chemistry and Chemical Engineering Key Laboratory of Chemical Additives for China National Light Industry Shaanxi University of Science and Technology Xi'an 710021 P. R. China

5. Guangdong Province Key Laboratory for Biotechnology Drug Candidates School of Bioscience and Biopharmaceutics Guangdong Pharmaceutical University Guangzhou 510006 P. R. China

Funder

National Key Research and Development Program of China

National Natural Science Foundation of China

Publisher

Wiley

Subject

Mechanical Engineering,Mechanics of Materials,General Materials Science

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3